Common Contracts

CLASS B STOCK PURCHASE WARRANT

Warrant Agreement • January 28th, 2008 • Viscorp, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Warrant Agreement
• Filed
  January 28th, 2008
• Company
  Viscorp, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

THIS CERTIFIES THAT, for value received, _______________________________, or its registered assigns, (the “Holder”) is entitled to purchase from VISCORP, INC. (to be renamed Tianyin Pharmaceutical Co., Inc.), a Delaware corporation, (the “Company”), at any time or from time to time during the period specified in Section 2 hereof, that that number of shares of the Company’s Common Stock, without par value per share (the “Common Stock”), as shall be equal to fifty percent (50%) of the number of shares of Common Stock (the “Conversion Shares”) that are issuable upon conversion of the amount of Series A Preferred Stock of the Company to be received by the Holder in exchange for his or its Note, all pursuant to the terms and conditions of the “Securities Purchase Agreement” (as hereinafter defined), at an exercise price of equal to (U.S.) $3.00 per share (the “Exercise Price”).

CLASS B STOCK PURCHASE CLASS A WARRANT

Warrant Agreement • January 18th, 2008 • Viscorp, Inc. • Services-business services, nec • New York

• Contract Type
  Warrant Agreement
• Filed
  January 18th, 2008
• Company
  Viscorp, Inc.
• Industry
  Services-business services, nec
• Jurisdiction
  New York

THIS CERTIFIES THAT, for value received, _______________________________, or its registered assigns, (the “Holder”) is entitled to purchase from VISCORP, INC. (to be renamed Tianyin Pharmaceutical Co., Inc.), a Delaware corporation, (the “Company”), at any time or from time to time during the period specified in Section 2 hereof, that that number of shares of the Company’s Common Stock, without par value per share (the “Common Stock”), as shall be equal to fifty percent (50%) of the number of shares of Common Stock (the “Conversion Shares”) that are issuable upon conversion of the amount of Series A Preferred Stock of the Company to be received by the Holder in exchange for his or its Note, all pursuant to the terms and conditions of the “Securities Purchase Agreement” (as hereinafter defined), at an exercise price of equal to (U.S.) $3.00 per share (the “Exercise Price”).